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Short Communication
Homozygous deletion of exon 18 leads to 
degradation of the lysosomal a-glucosidase 
precursor and to the infantile form of 
glycogen storage disease type
Ausem s MGEM, Kroos M A, Van der Kraan M, Smeitink JAM, Kleijer WJ, 
Ploos van Am stel HK, Reuser AJJ. H om ozygous deletion o f  exon 18 leads to 
degradation o f the lysosom al a-glucosidase precursor and to the infantile 
form of glycogen storage disease type II.
Clin Genet 1996: 49: 3 2 5 -3 2 8 . © Munksgaard, 1996
We describe two unrelated Dutch patients with typical symptoms o f infantile 
glycogen storage disease type II (G SD II) and virtual absence o f acid a -g lu ­
cosidase activity in leukocytes and cultured skin fibroblasts. The patients 
were identified as hom ozygotes for a deletion o f exon 18 o f  the acid a -g lu ­
cosidase gene (G A A ). The in-frame deletion manifests at the protein level in 
a characteristic way: the enzym e precursor is smaller than normal and 
degraded in the endoplasm ic reticulum or Golgi com plex. These cases present 
an evident exam ple o f a genotype-phenotype correlation in glycogen storage 
disease type II.
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ciency of acid a-glucosidase (McKusick 1994). The 
disease is characterized by lysosomal accumulation 
of glycogen, affecting muscle function and leading 
to muscle wasting. Early- and late-onset phenotypes 
are distinguished. The major difference is cardiac 
involvement and early demise in the first phenotype, 
and slowly progressive muscle degeneration in the 
second (Hirschhorn 1995).
One of the aims of current research on GSD II is 
to establish a genotype-phenotype correlation. The of genotype and phenotype. These mutations are the
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-13T—>G transversion in intron 1, promoting aber­
rant splicing and loss of exon 2 (Huie et al. 1994b, 
Boerkoel et al. 1995), the single base-pair deletion 
ÀT525 (Hermans et al. 1994), and the deletion of 
exon 18 (Boerkoel et al. 1992, Huie et al. 1994a, 
Van der Kraan et al. 1994, Boerkoel et al. 1995).
In this paper we describe two unrelated patients 
with infantile onset GSD II, who are both homozy­
gotes for the exon 18 deletion and show the direct 
effect of this mutation on acid a-glucosidase syn­
thesis and function.
M l-t 1-2 li-1 B C
•. V v ' : - ' U ; -. '  '  '  : '  '  '  V ; 1
• V vV*. 
■ V ' V v V i *
«.V • V- '1 • V / '• ')<* • • 
v  V y ,1 'j  ¿ t ó  * ï£i '  •
è*
t
c
mmm
fk .
Case reports
Patient A (cell line 93RD148) was the second male 
child of healthy, non-consanguineous Dutch Cauca­
sian parents. He presented with prolonged jaundice 
3 weeks after birth. At age 2.5 months, hypotonia, 
tachypnea and a cardiac murmur were noticed. 
Ultrasound of the heart demonstrated a hypertrophic 
cardiomyopathy. A severe deficiency of acid a-glu­
cosidase was demonstrated in leukocytes (not 
shown) and cultured fibroblasts (Table 1). The boy 
died at the age of 4 months.
Patient B (cell line 80RD156) was the third male 
child of healthy, non-consanguineous Dutch Cauca­
sian parents. By history he was hypotonic from the 
age of 6 weeks. At presentation at age 5 months,
Fig. 1. Detection of the exon 18 deletion in patient A by PCR 
and agarose gel electrophoresis. Control individuals (C) have a 
fragment of 925 bp. Patient A (II-1) has a smaller fragment of 
390 bp. His parents (1-1 and 1-2) have both the smaller (390 bp) 
and the normal (925 bp) fragments. The additional band with 
an intermediate migration was identified by PCR analysis as a 
heteroduplex of normal and mutant fragments. M is a marker 
and B is a blank.
|iM EDTA; 16.6 mM (NH4)2S 0 4; 10% dimethylsul- 
foxide and 40 U/ml of Taq-DNA polymerase (Cetus 
Corp, Emeryville, CA, USA).
Protein analysis
The biosynthesis of acid a-glucosidase in fibro-
severe hypotonia and areflexia were noticed. There blasts was monitored by pulse-chase labelling with
was a hypertrophic cardiomyopathy. Also, the acid 
a-glucosidase activity of this patient was practically
35S methionine (TranS, 1200 Ci/mmol, ICN) fol-
lowed by immunoprécipitation and SDS-polyacry- 
absent in fibroblasts (Table 1). The patient died at lamide gel electrophoresis, as described by Hermans
the age of 10 months. At autopsy, glycogen storage 
was demonstrated in heart, muscle, liver, kidneys
et al. (1994). In particular experiments, Brefeldin A
and peripheral nerves.
Material and methods
DNA analysis
High molecular weight DNA was isolated from cul­
tured fibroblasts according to established proce­
dures. The essential parts of the GAA gene were 
amplified using the polymerase chain reaction (Saiki 
et al. 1985). The exon 18 deletion was analyzed by 
amplification of exon 17 and 18 in tandem using the
(TGGTTCCTGAGGACAG-primers POM17F
CATG) (forward) and POM18R (AGTGGCAGG- 
TAGCCATCGGTG) (reverse). The amplification 
was performed in 33 cycles, each cycle consisting of 
1 min denaturation at 94°C, 1 min annealing at 55°C 
and 2 min extension at 72°C. The reaction mixture 
contained 400 ng of high molecular weight DNA, 
400 ng of each primer; 1.5 mM of each dNTP; 100 
jug/ml bovine serum albumin; 67 mM Tris-HCl (pH 
8.8); 6.7 mM MgCL; 10 mM (3-mercaptoethanol; 6.7
w  _<y
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chase (hr) 6 6 6 0 12 12
patient A 
0 12 12
patient B 
0 12 12
1 1 0 -
9 5 -
7 6 -
7 0 -
Brefeldin A
Fig. 2. Synthesis and processing of acid a-glucosidase in cul­
tured fibroblasts of patients A and B. Acid a-glucosidase was 
metabolically labelled for 3 h with 35S methionine. The cells 
were harvested after 0 ,6  and 12 h of chase. Where indicated (+) 
Brefeldin A was present during the pulse-chase period. Acid a -  
glucosidase was immuno-precipitated from the cell homoge- 
nates and analyzed by SDS-PAGE. The molecular mass of the 
various forms of acid a-glucosidase is indicated. The bands 
marked with an asterisk (*) are non-specific precipitation prod­
ucts which are not related to acid a-glucosidase synthesis and 
processing.
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Tablai. a-Glucosidase activities in two families with exon 18 deletion
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a The substrate used for the assay of acid a-glucosldase activity in fibro­
blasts Is 4-methylumbelllferyl-a-D-glucopyranoside according to Hermans 
et al, (1994). The activity is expressed in nmoi/h per mg protein; 
b Positive (+) and negative (--) identification of the Aexon 18 alleles is Indi­
cated.
was added to the culture medium in a concentration 
of 10 jlig/m 1 from 1 h prior to labelling till harvest.
This view is supported by two additional findings: 
the mutant precursor is not secreted and is not im- 
munologically detectable in lysosomes (results not 
shown). Since degradation of lysosomal glycogen 
requires the formation of 76 kD acid a-glucosidase, 
it is understandable that homozygosity for the exon 
18 deletion results in a complete loss of catalytic 
function (Table 1). The severe clinical phenotype of 
the patients is thereby explained.
These studies demonstrate the importance of fre­
quent mutations with well-defined functional effects 
for the establishment of a genotype-phenotype cor-
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Results and Discussion
Exon 17 and 18 of the lysosomal acid a-glucosidase 
gene (GAA) of the two patients with infantile GSD 
II were PCR amplified in tandem to possibly iden­
tify the frequently occurring exon 18 deletion. Fig. 1 
shows that abnormally small PCR fragments indica­
tive for the deletion were found, and that patient A 
is homozygous for the deletion. The amplified DNA 
fragment was directly sequenced, and this revealed 
the deletion to be identical to the one previously 
described by Huie et al. (1994a), Van der Kraan et 
al. (1994) and Boerkoel et al. (1995). Homozygosity 
for the exon 18 deletion was also detected in patient 
B (data not shown).
The effect of the exon 18 deletion on acid a-glu-
and function was studied by 
pulse-chase labelling of cultured fibroblasts. Fig. 2 
shows that deletion of exon 18 (coding for 55 amino
a-ea mutant ac 
reduced molecular mass
(less than the normal 110 kD) {() h of chase).
h of chase the wild-type had been con
proteolytically to 95 kD and 76 kD species
The mutant precursor had 
most disappeared. After 1 of
:ursor was no longer detectable. When Brefeldin 
s added (preventing exit of glycoproteins from 
endoplasmic reticulum and Golgi complex), the
normal precursor is proteolytically processed
but gains apparent molecular mass (Fig. 2) 1 
quisition of sialic acid residues (Wisselaar 
1993). The mutant precursor is not detectable 
these conditions, which is indicative for degra 
in the endoplasmic reticulum or Golgi cot
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